TNF and ulcerative colitis: So, in selected patients with moderate to severe active ulcerative colitis who have failed to respond or are poorly responsive to standard pharmacologic forms of treatment with corticosteroids and immunosuppressive agents, therapy with an anti-TNF-α agent may be considered.